AI assistant
Innoviva, Inc. — Director's Dealing 2010
Oct 28, 2010
32090_dirs_2010-10-28_3739c8ab-0ea4-4c86-b242-8382fe5265ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2010-10-26
Reporting Person: Shafer Bradford J (Sr VP, Gen. Counsel, Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-10-26 | Common Stock | A | 12500 | — | Acquired | 260077 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2750 | Indirect |
| Common Stock | 2750 | Indirect |
| Common Stock | 2750 | Indirect |
| Common Stock | 6451 | Indirect |
Footnotes
F1: On February 10, 2010, the reporting person was granted a restricted stock unit award (RSU) covering 25,000 shares of common stock. The RSU vests in quarterly installments over four years of service from the grant date, contingent upon the achievement of two performance goals. Upon the achievement of one of the two performance goals on October 26, 2010, half of the RSU began vesting.
F2: Shares held in trust for the benefit of a child of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.
F3: Shares held in trust for the benefit of the children of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.